Winetsky et al. (2012)
|
No TB / recovered 1.00
Active TB ± MDR, undiagnosed 0.73
Active TB ± MDR, AFB treated 0.68
Active TB ± MDR, AFB+ treated 0.60
|
Former Soviet Union prison inmates—unclear how preferences were elicited
|
Kittikraisak et al. (2012)
|
TB (treated) 0.65
MDR-TB (treated) 0.49
Cured TB ± MDR 0.89
HIV (no TB) 0.75
HIV with TB (treated) 0.62
Cured TB ± MDR with HIV 0.88
|
Thai patients diagnosed with TB (including those on treatment and those who had completed treatment) and/or HIV
EQ-5D weights adjusted for age and monthly household income (also presents unadjusted weights with standard error)
|
Awaisu et al. (2012)
|
At baseline 0.70
At 3 months treatment 0.87
At 6 months treatment 0.91
|
Malaysian smokers newly diagnosed with TB
EQ-5D weights for control group (treatment administered by DOTS)
|
Kruijshaar et al. (2010) (reported in Jit et al. (2011))
|
Untreated TB 0.68
After 2 months treatment 0.81
|
UK patients diagnosed with active TB were administered generic health-related quality-of-life questionnaires (EQ-5D and SF-36) at diagnosis and 2 months into therapy. The median time between questionnaires was 73 days (IQR: 54-104)
Overall scores are not reported in Krujisharr et al. (2010), but are reported in Jit et al. (2011)
|
Babikako et al. (2010)
|
At baseline 0.607
At 2 months treatment 0.671
At 8 months treatment 0.785
|
Ugandan patients with known HIV status and TB enrolled based on duration of TB therapy: started at 2 months and completed at 8 months
|
Guo et al. (2008)
|
Active TB (treated) 0.68 (0.65–0.72)
By severity of TB symptoms:
Very mild 0.84 (0.11)
Mild 0.68 (0.05)
Moderate 0.64 (0.10)
Severe 0.59 (0.15)
Very severe 0.54 (0.08)
|
Canadian patients with recent diagnosis of active TB (within 2 months)
Measure using the SF-6D (also HUI2, HUI3 and VAS)
Also reports by self-reported symptom control
|